A Live-Attenuated ΔNcROM6 Strain Induces Protective Immunity Against Neospora caninum Infection in Mice and Sheep.
Chen Sining S, Yu Qile Q, Du Boya B, Wang Jixia J et al.
Neospora caninum (N. caninum) is a protozoan parasite associated with bovine and sheep abortion and canine neurological disorders. However, effective treatments and vaccines for controlling neosporosis remain limited. Rhomboid (ROM) serine proteases mediate apicomplexan invasion, but their function in N. caninum remains unclear. Here, CRISPR-Cas9 was used to construct the NcROM6 gene knockout strain (ΔNcROM6), whose phenotypic traits and potential as a live-attenuated vaccine were evaluated in mouse and sheep models. NcROM6 deficiency markedly impaired in vitro invasion, egress, and intracellular proliferation. All mice infected with 2.5 × 107 ΔNcROM6 tachyzoites survived, with tissue parasite burdens reduced by 68.30%-100% and attenuated tissue lesions. Neither residual virulence nor vertical transmission was detected postimmunization with 5 × 106 ΔNcROM6 tachyzoites, supporting vaccine biosafety. ∆NcROM6 elicited high titers of specific IgG2c, activated CD4+ T cells, and induced a mixed Th1/Th2 immune response, encompassing both humoral and cellular immunity. Immunized mice exhibited 100% survival against both acute and chronic N. caninum infection, and an 86.12% reduction in brain cyst burden against chronic infection. In sheep, immunization with ∆NcROM6 elicited persistent and significantly elevated levels of cytokines against N. caninum, resulting in significantly reduced parasite burdens across multiple tissues, and substantially ameliorated tissue lesions. Collectively, ΔNcROM6 provides reliable and effective protection against N. caninum infection in both mouse and sheep models, indicating it as a promising live-attenuated vaccine candidate for controlling neosporosis in livestock.